Sign in

CIK 0001368514

  • Large accelerated filer

ADMA BIOLOGICS, INC.

Sign in to watch
Ticker
ADMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562590442
Phone
+1 201-478-5552
Business address
C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
Former names
R&R ACQUISITION VI, INC
  1. 4 Shares withheld for taxes President and CEO gave up 18,718 shares (to pay taxes)
  2. 4 Shares withheld for taxes EVP, CFO gave up 15,268 shares (to pay taxes)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market buy Director bought 130,000 shares at $3.71 ($482,144)
  5. 4 Open-market buy Director bought 25,000 shares at $3.90 ($97,500)
  6. 4 Open-market sale Director sold 1,433,304 shares at $3.87 ($5,544,737)
  7. 4 Open-market sale President and CEO sold 250,000 shares at $4.15 ($1,038,350)
  8. 4 Open-market sale President and CEO sold 510,472 shares at an average $4.54 ($2,318,972)
  9. 4 Open-market sale EVP, CFO sold 389,762 shares at an average $4.53 ($1,766,130)
  10. 4 Shares withheld for taxes EVP, CFO gave up 15,268 shares (to pay taxes)
  11. 4 Shares withheld for taxes President and CEO gave up 20,051 shares (to pay taxes)
  12. 4 Shares withheld for taxes EVP, CFO gave up 15,469 shares (to pay taxes)
  13. 4 Shares withheld for taxes President and CEO gave up 17,853 shares (to pay taxes)
  14. 4 Shares withheld for taxes President and CEO gave up 49,544 shares (to pay taxes)
  15. 4 Shares withheld for taxes EVP, CFO gave up 31,451 shares (to pay taxes)
  16. 4 Grant or award Director acquired 25,815 shares (grant or award)
  17. 4 Grant or award Director acquired 25,815 shares (grant or award)
  18. 4 Grant or award Director acquired 25,815 shares (grant or award)
  19. 4 Grant or award Director acquired 25,815 shares (grant or award)
  20. 4 Grant or award Director acquired 25,815 shares (grant or award)

Page 6 of 19 · 362 filings